The core of Agenus’ operations revolves around harnessing the strength of the immune procedure to focus on and handle challenging-to-handle cancers and infections. The corporation’s product or service candidates are built to educate and activate immune responses by specifically concentrating on cancer cells, thus presenting likely new avenues i